Tag: PathMaker Neurosystems
PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment
PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...
Companies partner for a non-invasive neuromodulation device to treat spasticity
WeHealth by Servier, the e-health department of Servier Group, and PathMaker Neurosystems, have announced the closing of a partnership agreement to develop and commercialise...